Walleye Capital LLC Curis Inc Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
SELL
$0.71 - $2.43 $597,673 - $2.05 Million
-841,793 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$2.31 - $5.13 $1.88 Million - $4.18 Million
814,951 Added 3036.1%
841,793 $2 Million
Q4 2021

Mar 03, 2022
BUY
$4.45 - $8.09 $119,446 - $217,151
26,842 New
26,842 $127,000

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $298M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email